Chemotherapy for Metastatic Colorectal Cancer

Author： Rosales Joseph   Leong Lucille A.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.3, Iss.4, 2005-07, pp. : 525-529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral chemotherapy saves money in metastatic colorectal cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 511, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Bevacizumab plus FOLFIRI-3 in chemotherapy-refractory patients with metastatic colorectal cancer in the era of biotherapies

By Ghiringhelli François  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 758-764

Springer Publishing Company

Access to resources Recommend Favorite

Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer

By Mack Jennifer W.   Walling Anne   Dy Sydney   Antonio Anna Liza M.   Adams John   Keating Nancy L.   Tisnado Diana  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1891-1897

Blackwell Publishing

Access to resources Recommend Favorite

Panitumumab: In the Treatment of Metastatic Colorectal Cancer

By Hoy Sheridan M.   Wagstaff Antona J.  

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 2005-2014

Adis International

Access to resources Recommend Favorite

FOLFOXIRI promising in metastatic colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite